Apply to receive up to $5,000 toward your education and becoming an agent of change in the epilepsy community.
Death certification in status epilepticus is likely to be an underestimate of the reality. Further efforts are urgently needed to determine the extent of status epilepticus-related deaths and all deaths in patients with epilepsy.
The trial achieved its primary endpoint of safety and tolerability and showed OV935 was generally well tolerated.
Genetics, Pediatric Epilepsy
A round-up of the top epilepsy research news from the past month.
RogCon and The Florey Institute of Neuroscience presented preclinical data on the company's lead program, RC-222, an antisense oligonucleotide designed to down-regulate SCN2A.
Pediatric Epilepsy
A retrospective study evaluating continuous electroencephalography (cEEG) of children in intensive care units (ICUs) found a higher than anticipated number of seizures.
Three FDA-approved drugs designed to treat other conditions significantly reduced seizure-like movement in zebrafish.
Discover the latest about what's happening at CURE and in our community in the December 2018 CURE Update from Chief Scientific Officer, Laura Lubbers!
Pediatric Epilepsy
Study finds the Refractory Epilepsy Screening Tool for LGS may be a valuable clinical tool in identifying patients requiring further diagnostic evaluation for LGS.
